Figure 1From: Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukesTCBZ.SO plasma concentrations. Comparative mean (±SD) plasma concentration profiles for triclabendazole sulphoxide (TCBZ.SO) measured after the administration of triclabendazole (TCBZ) either alone or co-administered with ivermectin (IVM) and methimazole (MTZ) to Fasciola hepatica-infected sheep.Back to article page